Bristol Myers Squibb Stock Buy Hold or Sell Recommendation
| BMY Stock | USD 59.27 0.53 0.90% |
Considering the 90-day investment horizon and your above-average risk tolerance, our recommendation regarding Bristol Myers Squibb is 'Strong Buy'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Bristol Myers Squibb given historical horizon and risk tolerance towards Bristol Myers. When Macroaxis issues a 'buy' or 'sell' recommendation for Bristol Myers Squibb, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Bristol Myers Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Bristol and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Bristol Myers Squibb. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
Bristol |
Execute Bristol Myers Buy or Sell Advice
The Bristol recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Bristol Myers Squibb. Macroaxis does not own or have any residual interests in Bristol Myers Squibb or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Bristol Myers' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Buy
Market Performance | Good | Details | |
Volatility | Very steady | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Barely shadows the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Strong | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Possible Manipulator | Details |
Bristol Myers Trading Alerts and Improvement Suggestions
| Bristol Myers Squibb has a strong financial position based on the latest SEC filings | |
| Over 78.0% of the company shares are held by institutions such as insurance companies | |
| On 1st of November 2024 Bristol Myers paid $ 0.6 per share dividend to its current shareholders | |
| Latest headline from patch.com: 6 More Victims Were Drugged, Raped By Bristol Twp Man Bucks DA |
Bristol Myers Returns Distribution Density
The distribution of Bristol Myers' historical returns is an attempt to chart the uncertainty of Bristol Myers' future price movements. The chart of the probability distribution of Bristol Myers daily returns describes the distribution of returns around its average expected value. We use Bristol Myers Squibb price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Bristol Myers returns is essential to provide solid investment advice for Bristol Myers.
| Mean Return | 0.33 | Value At Risk | -2.07 | Potential Upside | 2.23 | Standard Deviation | 1.97 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Bristol Myers historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Bristol Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument, such as Bristol Myers, soars without any apparent reason? This usually happens because many institutional investors are aggressively trading Bristol Myers Squibb back and forth among themselves.
| Shares | Northern Trust Corp | 2024-09-30 | 21.2 M | Legal & General Group Plc | 2024-06-30 | 20.2 M | Ubs Asset Mgmt Americas Inc | 2024-09-30 | 19.1 M | Bank Of America Corp | 2024-06-30 | 18.2 M | Ameriprise Financial Inc | 2024-06-30 | 17.7 M | Bank Of New York Mellon Corp | 2024-06-30 | 16.2 M | Goldman Sachs Group Inc | 2024-06-30 | 15.7 M | Dodge & Cox | 2024-09-30 | 15.6 M | T. Rowe Price Associates, Inc. | 2024-06-30 | 15.3 M | Vanguard Group Inc | 2024-09-30 | 188.6 M | Blackrock Inc | 2024-06-30 | 158.7 M |
Bristol Myers Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | 463M | 2.7B | 13M | (69M) | (751M) | (713.5M) | |
| Change In Cash | 5.9B | 2.2B | (657M) | (5.0B) | 2.2B | 2.3B | |
| Free Cash Flow | 7.2B | 13.3B | 15.2B | 11.9B | 12.7B | 13.3B | |
| Depreciation | 1.7B | 10.4B | 10.7B | 10.3B | 9.8B | 10.2B | |
| Other Non Cash Items | 279M | 9.9B | 570M | 955M | 744M | 781.2M | |
| Dividends Paid | 2.7B | 4.1B | 4.4B | 4.6B | 4.7B | 2.5B | |
| Capital Expenditures | 836M | 753M | 973M | 1.1B | 1.2B | 837.5M | |
| Net Income | 3.5B | (9.0B) | 7.0B | 6.3B | 8.0B | 8.4B | |
| End Period Cash Flow | 12.8B | 15.0B | 14.3B | 9.3B | 11.5B | 12.1B | |
| Change To Netincome | (62M) | (197M) | (748M) | (1.1B) | (970.2M) | (921.7M) | |
| Investments | (152M) | 2.1B | 1.3B | 3.0B | 264M | 270.6M | |
| Change Receivables | 752M | (646M) | (1.1B) | (663M) | (596.7M) | (566.9M) | |
| Net Borrowings | 17.7B | 3.9B | (6.2B) | (5.3B) | (6.1B) | (5.8B) |
Bristol Myers Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Bristol Myers or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Bristol Myers' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Bristol stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.31 | |
β | Beta against Dow Jones | 0.08 | |
σ | Overall volatility | 2.00 | |
Ir | Information ratio | 0.10 |
Bristol Myers Volatility Alert
Bristol Myers Squibb has relatively low volatility with skewness of 2.22 and kurtosis of 10.69. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Bristol Myers' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Bristol Myers' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Bristol Myers Fundamentals Vs Peers
Comparing Bristol Myers' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Bristol Myers' direct or indirect competition across all of the common fundamentals between Bristol Myers and the related equities. This way, we can detect undervalued stocks with similar characteristics as Bristol Myers or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Bristol Myers' fundamental indicators could also be used in its relative valuation, which is a method of valuing Bristol Myers by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Bristol Myers to competition |
| Fundamentals | Bristol Myers | Peer Average |
| Return On Equity | -0.31 | -0.31 |
| Return On Asset | 0.0607 | -0.14 |
| Profit Margin | (0.15) % | (1.27) % |
| Operating Margin | 0.18 % | (5.51) % |
| Current Valuation | 162.52 B | 16.62 B |
| Shares Outstanding | 2.03 B | 571.82 M |
| Shares Owned By Insiders | 0.11 % | 10.09 % |
| Shares Owned By Institutions | 78.41 % | 39.21 % |
| Number Of Shares Shorted | 23.42 M | 4.71 M |
| Price To Earning | 24.88 X | 28.72 X |
| Price To Book | 6.95 X | 9.51 X |
| Price To Sales | 2.51 X | 11.42 X |
| Revenue | 45.01 B | 9.43 B |
| Gross Profit | 36.38 B | 27.38 B |
| EBITDA | 19.42 B | 3.9 B |
| Net Income | 8.04 B | 570.98 M |
| Cash And Equivalents | 9.12 B | 2.7 B |
| Cash Per Share | 6.21 X | 5.01 X |
| Total Debt | 41.46 B | 5.32 B |
| Debt To Equity | 1.32 % | 48.70 % |
| Current Ratio | 1.42 X | 2.16 X |
| Book Value Per Share | 8.45 X | 1.93 K |
| Cash Flow From Operations | 13.86 B | 971.22 M |
| Short Ratio | 2.30 X | 4.00 X |
| Earnings Per Share | (3.58) X | 3.12 X |
| Price To Earnings To Growth | 2.05 X | 4.89 X |
| Target Price | 59.64 | |
| Number Of Employees | 34.1 K | 18.84 K |
| Beta | 0.44 | -0.15 |
| Market Capitalization | 119.14 B | 19.03 B |
| Total Asset | 95.16 B | 29.47 B |
| Retained Earnings | 28.77 B | 9.33 B |
| Working Capital | 9.51 B | 1.48 B |
Note: Acquisition by Peter Arduini of 825 shares of Bristol Myers subject to Rule 16b-3 [view details]
Bristol Myers Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Bristol . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Bristol Myers Buy or Sell Advice
When is the right time to buy or sell Bristol Myers Squibb? Buying financial instruments such as Bristol Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Bristol Myers in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Chemicals Thematic Idea Now
Chemicals
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Chemicals theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Chemicals Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Bristol Stock Analysis
When running Bristol Myers' price analysis, check to measure Bristol Myers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myers is operating at the current time. Most of Bristol Myers' value examination focuses on studying past and present price action to predict the probability of Bristol Myers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol Myers' price. Additionally, you may evaluate how the addition of Bristol Myers to your portfolios can decrease your overall portfolio volatility.